This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
31 Oct 2025

BFS-Piracetam (Piracetam 1000 mg/5 ml - Solution for injection)

BFS-Piracetam (Piracetam 1000 mg/5 ml - Solution for injection)

Composition: Piracetam 1000 mg/5 ml.


Dosage Form: Solution for injection.


Indication: Piracetam is administered intravenously and intramuscularly on serious cerebral diseases, states of coma, as well as for arresting of abstinent, preliminary or delirious states or acute complications occurred in the period of psychopharmacotherapy.

Dosage Adminstration: The preparation is administered intramuscularly or intravenously in adults starting with the dose of 2-4 g and then the dose can be immediately increased up to 4-6 g per day. The duration of treatment and the individual dose depend on the disease severity and reverse dynamics speed of the clinical presentation. For treatment of ischemic stroke piracetam is administered drop-by-drop in the doses 4-12 g per day during 2-4 weeks.


Amelioration being achieved, piracetam for oral administration should be prescribed.


For treatment of acute brain injuries piracetam is prescribed in the complex with other disintoxication and rehabilitation therapy, and for treatment of psychiatric diseases – with corresponding psychotropic agents.


Administration of piracetam can be sometimes accompanied by administration of psychotropic, cardiovascular and other medicines.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile